FindTrial
Sign In

Improvement in Baroreflex Sensitivity in OSAS

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00284037
Enrollment
Unknown
Registered
2006-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2006-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Keywords

obstructive sleep apnea,, baroreceptors

Brief summary

Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.

Interventions

DEVICEcontinuous positive airway pressure therapy

Sponsors

Nagoya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years

Inclusion criteria

* obstructive sleep apnea syndrome

Exclusion criteria

* diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.

Countries

Japan

Contacts

Primary ContactAkiko Noda, PhD
a-noda@met.nagoya-u.ac.jp+81-52-719-1537

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026